SCHEMBL24700268

SCHEMBL24700268

CC(C)(C)OC(=O)N1CCN(c2ccccc2)C(=O)C1(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.48
NR1H2 P55055 1/20 0.46
NR1H3 Q13133 1/20 0.46
GPR119 Q8TDV5 2/20 0.45
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRM5 P41594 1/20 0.37
GRM1 Q13255 1/20 0.37
METAP2 P50579 1/20 0.36
BUB1 O43683 1/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18096408 0.86 GPR119 (0.51) USP30NR1H2NR1H3GPR119MEN1
SCHEMBL23123296 0.84 SIGMAR1 (0.44) MEN1KMT2A
SCHEMBL24794735 0.82 USP30 (0.40) USP30NR1H2NR1H3GPR119ALDH1A1
SCHEMBL29709670 0.82 USP30 (0.40) USP30NR1H2NR1H3GPR119ALDH1A1
SCHEMBL18096081 0.81 SCD (0.44) USP30MAPTLMNAPIK3CD
SCHEMBL22054798 0.80 PIK3CD (0.49) MEN1NPC1RAB9AKMT2APIK3CD
SCHEMBL18096171 0.80 PIK3CD (0.39) USP30NR1H2NR1H3GPR119MAPT
SCHEMBL24794000 0.76 POLB (0.38) USP30MEN1KMT2AALDH1A1MAPT
SCHEMBL3209146 0.76 GRIN2B (0.41) NR1H2NR1H3GPR119ALDH1A1MAPT
SCHEMBL24794180 0.76 CREBBP (0.39) USP30MEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220380314-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL R&D INVEST S A (PT) 2022-12-01 US disclosed
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220380314-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GBA2, CLN6 USP30 2436/4885NR1H2 445/4885NR1H3 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.